Global Health Limited reported earnings results for the second quarter and six months ended September 30, 2024. For the second quarter, the company reported sales was INR 9,565.55 million compared to INR 8,504.46 million a year ago. Revenue was INR 9,747.71 million compared to INR 8,646.9 million a year ago. Net income was INR 1,308.44 million compared to INR 1,251.61 million a year ago. Basic earnings per share from continuing operations was INR 4.87 compared to INR 4.66 a year ago. Diluted earnings per share from continuing operations was INR 4.87 compared to INR 4.66 a year ago.
For the six months, sales was INR 18,176.32 million compared to INR 16,300.26 million a year ago. Revenue was INR 18,577.75 million compared to INR 16,591.88 million a year ago. Net income was INR 2,371.3 million compared to INR 2,271.71 million a year ago. Basic earnings per share from continuing operations was INR 8.83 compared to INR 8.46 a year ago. Diluted earnings per share from continuing operations was INR 8.83 compared to INR 8.46 a year ago.
Global Health Limited (Medanta) is an India-based multi-specialty tertiary care provider in the North and East regions of India. Medanta delivers advanced, end-to-end healthcare in Delhi, Gurugram, Indore, Ranchi, Patna, and Lucknow through its network of approximately five hospitals. The Company provides healthcare services in over 30 medical specialties and engages over 1,700 doctors, which is led by experienced department heads. Its speciality treatments are in cardiac care, cancer care, neurosciences, gastrosciences, orthopedics, renal care, liver transplant, oncology, bone marrow transplant, obstetrics and gynecology, chest surgery, lung transplant, pediatric care, and others. Its facilities and services include medicine delivery, lab tests & diagnostics, book homecare services, elder care, air ambulance, and among others. The Company’s subsidiaries are Global Health Patliputra Private Limited, Medanta Holdings Private Limited, and GHL Pharma & Diagnostic Private Limited.
This super rating is the result of a weighted average of the rankings based on the following ratings: Global Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Global Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite), and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be performed. We recommend that you carefully review the associated descriptions.
Quality
Quality
This composite rating is the result of an average of the rankings based on the following ratings: Capital Efficiency (Composite), Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully review the associated descriptions.
ESG MSCI
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
